OnKure Therapeutics, Inc. (OKUR)
About OnKure Therapeutics, Inc.
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $0
- Net income
- -$59.5M
- Total assets
- $62.1M
- Market cap
- $169.3M
- Operating margin
- -1833.7%
- Net margin
- -1733.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $3.4M
- Operating expenses
- $63.0M
- Operating income
- -$63.0M
- Income tax
- $0
- Net income
- -$59.5M
- EPS (basic)
- $-4.40
- EPS (diluted)
- $-4.40
Balance sheet
- Total assets
- $62.1M
- Current assets
- $60.8M
- Total liabilities
- $5.9M
- Current liabilities
- $5.9M
- Shareholders’ equity
- $56.2M
Cash flow
- Operating cash flow
- -$51.8M
- Investing cash flow
- -$46.0K
- Financing cash flow
- $163.0K
- Net cash flow
- -$51.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $169.3M
- EPS (diluted)
- $-4.4
- Shares outstanding
- 41.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 7, 2024
OnKure Therapeutics, Inc. (OKUR) Stock Price
- Reported a net loss of $59.5M in FY2024.
- Trading 22% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review OnKure Therapeutics, Inc..
Write a review
News about OnKure Therapeutics, Inc.
News & sentiment via Polygon.io
OnKure Therapeutics, Inc.: frequently asked questions
Is OnKure Therapeutics, Inc. an American company?
OnKure Therapeutics, Inc. is a US-based company headquartered in Boulder, Colorado, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is OnKure Therapeutics, Inc. headquartered?
OnKure Therapeutics, Inc. is headquartered in Boulder, Colorado, United States.
Is OnKure Therapeutics, Inc. publicly traded?
Yes — OnKure Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol OKUR on the NASDAQ.
What does OnKure Therapeutics, Inc. do?
OnKure Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
